The JCI is the publication of the American Society for Clinical Investigation, an honor society of physician-scientists.

Copyright © The American Society for Clinical Investigation.
Copying, redistribution, and other usage policies
Cover story: Jettisoning jet lag
What are the molecular events that allow us to overcome jet lag? Kiessling and colleagues report that jet lag temporarily disrupts the body’s circadian clock but can be adjusted through rhythmic release of glucocorticoids (page 2600).
Cover image courtesy of Merve Ulug Evern.
Also inside:
In placental mammals, sexual reproduction is a highly complex and tightly controlled process that begins with germ cell development and ends with the birth of live young. The articles in this series comprise an overview of our current understanding of many of the events crucial to sexual reproduction in placental mammals and point to some of the ways forward to moving from “bench-to-bedside” to enhance pregnancy success rates in fertility clinics.
Stem Cells
View previous series
Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks
RELATED COMMENTARY
Mice that “conditionally” lack basophils, AT LAST
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
RELATED COMMENTARY
Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?
Nicotinic acid– and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
RELATED COMMENTARY
Seeing red: flushing out instigators of niacin-associated skin toxicity
Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
RELATED COMMENTARY
Semaphorin 3E, an exception to the rule
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
RELATED COMMENTARY
PIK3CA and KRAS mutations predict for response to everolimus therapy: now that’s RAD001